This webinar will explain the final version of USP Chapter <1224> and FDA guidance for conducting and documenting method transfer between laboratories and sites, and provide tools for effective implementation.
Why Should You Attend:
When validated methods are transferred between laboratories and sites, their validated state should be maintained to ensure the same reliable results in the receiving laboratory. So far there has not been an official guidance on what exactly is expected to maintain 'the validated state'. Now the USP has published the final version of the general chapter <1224>.
Also the FDA has released an official guidance on how to conduct and document method transfer and FDA is starting to enforce the new USP chapter. Now it is a good time to learn how to conduct and document method transfer.
This session will equip participants with a comprehensive understanding of USP and FDA requirements for transfer of analytical methods and provide recommendations and tools for effective implementation.
Added by complianceonlinecom on November 19, 2012